Basilea Pharmaceutica 2020 Investor Presentation

Basilea Pharmaceutica is a commercial-stage biotech company focused on oncology and infectious diseases, with two revenue-generating hospital anti-infective brands (Cresemba and Zevtera) and two clinical oncology candidates in development. Listed on the SIX Swiss Stock Exchange, the company combines established commercial products with an innovative pipeline for sustainable growth.